Cited by 416Inflammatory Bowel DiseaseHealth Systems, Economic Evaluations, Quality of LifeOcular Diseases and Behçet’s Syndrome

The DOI matches its Crossref record; 144 of the 146 references it cites were found in a registry or an index.

Quality of Life in Inflammatory Bowel Disease: A Systematic Review and Meta-analyses—Part II

Open access
Knowles, Simon R, Keefer, Laurie, Wilding, Helen, Hewitt, Catherine, Graff, Lesley A, Mikocka-Walus, Antonina·2018·Inflammatory Bowel Diseases

Abstract

Background: There has been burgeoning interest in quality of life (QoL) in inflammatory bowel disease (IBD) in recent decades, with hundreds of studies each year now assessing this outcome. This paper is part 2 of a systematic review evaluating 5 key QoL comparisons within IBD states and relative to others without IBD. Part 1 examined QoL comparing IBD and a healthy/general population and other medically ill groups. Part 2, presented here, examines within-disease comparisons of active/inactive disease, Ulcerative colitis (UC) / Crohn's disease (CD), and change in QoL over time. Outcomes using generic versus IBD-specific QoL measures were also examined. Methods: Adult and pediatric studies were identified through systematic searches of 7 databases from the 1940s (where available) to October 2015. Results: Of 6173 abstracts identified, 466 were selected for final review based on controlled design and validated measurement, of which 83 unique studies (75 adult, 8 pediatric) addressed the within-disease comparisons. The pooled mean QoL scores were significantly lower in active versus inactive IBD (n = 26) and for those with CD versus UC (n = 37), consistent across IBD-specific and generic QoL measures, for almost all comparisons. There was significant improvement in QoL over time (n = 37). Study quality was generally low to moderate. The most common measures of QoL were the disease-specific Inflammatory Bowel Disease Questionnaire and generic 36-Item Short Form Survey (SF-36) (adults) and the IBD-specific IMPACT (children). Conclusions: For adults in particular, there was strong confirmation that QoL is poorer during active disease and may be poorer for those with CD. The finding that QoL can improve over time may be encouraging for individuals with this chronic disease.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/ibd/izy015

Cites

144 of 144 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Flagged first, then by citations

Show all 146 references

2 of the 146 references couldn’t be matched to a known paper.

Research works printed but not linked: 1

  1. Tragnone, 1996, Quality of life and inflammatory bowel disease, Gastroenterol, 9, 47

Cited by

Sorted by citations

Items 101–200 of 415

Metadata

Authors
Knowles, S. R., Keefer, L., Wilding, H., Hewitt, C., Graff, L. A., & Mikocka-Walus, A.
Affiliations
  • The Royal Melbourne Hospital (AU)
  • Icahn School of Medicine at Mount Sinai (US)
  • St Vincent's Hospital Melbourne (AU)
  • University of York (GB)
  • University of Manitoba (CA)
  • Department of Health Sciences, University of York, York, United Kingdom
Corresponding author
Knowles, Simon R
Venue
Inflammatory Bowel Diseases
Published
2018-04-23
Volume
24
Issue
5
Pages
966-976
ISSN
  • 1078-0998 (ISSN-L)
  • 1536-4844
OpenAlex
W2801602793
Cited by
416
References
146
Citations by year
2026: 26 · 2025: 53 · 2024: 73 · 2023: 83 · 2022: 55 · 2021: 61 · 2020: 35 · 2019: 24 · 2018: 6
FWCI
4.57
Type
journal article
Language
en
Open access
Locations
  • Inflammatory Bowel Diseases (publishedVersion)
  • PubMed (publishedVersion)
  • Own your potential (DEAKIN) (submittedVersion)
  • Figshare (submittedVersion, cc-by)
  • Swinburne figshare (Swinburne University of Technology) (submittedVersion)
Topics
  • Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
  • Social Sciences › Economics, Econometrics and Finance › Economics and Econometrics › Health Systems, Economic Evaluations, Quality of Life
  • Health Sciences › Medicine › Ophthalmology › Ocular Diseases and Behçet’s Syndrome
Keywords
quality of life, inflammatory bowel disease
MeSH terms
Adult, Child, Colitis, Ulcerative, Crohn Disease, Humans, Quality of Life, Surveys and Questionnaires

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review